List view / Grid view
10 March 2016 | By Victoria White
Scientists are a step closer to creating blood stem cells that could reduce the need for bone marrow transplants in patients with cancer or blood disorders...
2 March 2016 | By Victoria White
Researchers have discovered that a GSK-J4 can kill acute lymphoblastic leukaemia that involves the TAL-1 gene...
24 February 2016 | By Victoria White
Researchers at The Ohio State University are working on a new way to treat drug-resistant cancer that uses DNA origami packaging...
1 February 2016 | By Victoria White
Nordic Nanovector has been awarded the NOK 15 million grant from the Research Council of Norway’s User-driven Research-based Innovation programme...
4 January 2016 | By Victoria White
UCART19 is a potential best-in-class allogeneic Talen gene edited T-cell product for treatment of CD19 expressing haematological malignancies...
20 October 2015 | By Victoria White
The surprise finding could lead to a powerful new therapy for leukaemia and possibly other cancers...
12 October 2015 | By Victoria White
Boehringer Ingelheim and Philogen have agreed on an exploratory trial investigating novel immunotherapy concepts for relapsed acute myeloid leukaemia patients...
29 July 2015 | By Victoria White
An international team of scientists have succeeded in decoding the molecular characteristics of an as yet incurable subtype of leukaemia...
5 May 2015 | By
Researchers led by St. Jude Children’s Research Hospital scientists have identified a mechanism that helps leukaemia cells resist glucocorticoids...
30 April 2015 | By Victoria White
Researchers have found that ITIM - receptors are important to the development of acute myeloid leukaemia (AML), providing a target for potential therapies...
